Skip to content

Clinical Trial of Thoracoscopic Bullectomy Surgery Under Spontaneous Ventilating Anesthesia

Multicenter Randomized Controlled Clinical Trial of Thoracoscopic Bullectomy Surgery Under Nonintubated Intravenous Anesthesia With Spontaneous Ventilation

Status
UNKNOWN
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03016858
Enrollment
320
Registered
2017-01-11
Start date
2016-12-31
Completion date
2019-12-31
Last updated
2019-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Complication, Postoperative, Postoperative Hospitalization Time, Stability During Surgical Operation

Brief summary

With the development of video-assisted thoracoscopic surgery (VATS) techniques and technology for anesthesia control, non-intubated anesthesia with spontaneous ventilation has been widely applied in VATS. A multicenter randomized parallel controlled study was applied in this study to assess the efficacy and safety of thoracoscopic bullectomy surgery under intravenous anesthesia with spontaneous ventilation versus tracheal intubation general anesthesia.

Detailed description

Intubated anesthesia with single lung mechanical ventilation (IASLV) is considered the standard of care in VATS. However, this type of anesthesia has been associated with several adverse effects, which can trigger complications and increase the overall surgical risk. In order to avoid intubated-anesthesia-related adverse effects, nonintubated strategies have been proposed in recent years.Encouraged by the satisfactory results with a preliminary experience of nonintubated VATS, the multicenter randomized parallel controlled study is established to comparatively analyze the outcome of patients undergoing either nonintubated intravenous anesthesia with spontaneous ventilation (NIIASV) or IASLV VATS thoracoscopic bullectomy surgery,especially in complication rate, safety during operation, muscle recovery after surgery, the difference the postoperative hospitalization time.

Interventions

PROCEDUREThoracoscopic Bullectomy Surgery

undergoing the Thoracoscopic Bullectomy Surgery

Sponsors

First Affiliated Hospital, Sun Yat-Sen University
CollaboratorOTHER
Taizhou Hospital
CollaboratorOTHER
The Second Hospital University of South China
CollaboratorOTHER
Affiliated Hospital of Southwest Medical University
CollaboratorOTHER
Nanfang Hospital, Southern Medical University
CollaboratorOTHER
Shenzhen Third People's Hospital
CollaboratorOTHER
Jieyang People's Hospital
CollaboratorOTHER
Guangzhou Institute of Respiratory Disease
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
16 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* volunteering to participate in clinical trials and having the ability of responsibility can be signed informed consent. * 16-50 years old * preoperative chest CT diagnosed with localized lung bulla and needing surgical treatment * Eastern Cooperative Oncology Group(ECOG) score standard ≤ 1 * ASA(American Society of Anesthesiologists score) ≤ 2 * Heart ejection fraction( EF)≥ 50%

Exclusion criteria

* refusing to participate in clinical trials * A history of tuberculosis or other diseases could cause pleural adhesion or more pleural effusion * BMI ≥ 25 kg/m\^2 * other not suitable situations

Design outcomes

Primary

MeasureTime frameDescription
numbers of participants with postoperative respiratory and cardiovascular complicationsfrom operation to discharging, an average of 1 weekThe numbers of participants with postoperative respiratory and cardiovascular complications will be reported. The postoperative complications include postoperative respiratory complications(e.g., air leaks, lung infections, atelectasis, and bronchospasm and respiratory failure), postoperative cardiovascular complications(e.g., arrhythmias, myocardial infarction, cardiac failure) , intubated related complications(e.g., hoarseness, sore throat, and irritating cough), and other undefined complications

Secondary

MeasureTime frameDescription
numbers of participants with unstable vital signs, hypoxemia or hypercapnia intraoperativelyduring the surgical operation, an average of 1 hourthe numbers of participants with unstable vital signs or hypoxemia/hypercapnia will be reported. The vital signs will be monitored through the whole surgical operation(including heart rating in beat per minute, temperature in degree Celsius, respiratory in breaths per minute and blood pressure in oxygen in millimetres of mercury ), and blood gas analysis((including partial pressure of oxygen in millimetres of mercury, partial pressure of carbon dioxide in millimetres of mercury, and so on) will be tested every 30 mins during the operation.
numbers of participants with anesthesia conversion intraoperatively in nonintubated groupduring the surgical operation, an average of 1 hourThe numbers of participants undergoing conversion from nonintubated anaesthesia to intubated anaesthesia in nonintubated group will be reported because of hypoxemia, carbohemia, bleeding or other undefined reasons.
numbers of participants with postoperative complicationsfrom operation to discharging, an average of 1 weekThe numbers of participants with any postoperative complications will be reported.

Other

MeasureTime frameDescription
the postoperative hospitalization time of every participantthrough the postoperative hospitalization time, an average of 1 week)the postoperative time point of participants meeting the discharging criteria: body T°\<37.5℃, degree of blood oxygen saturation on room air\>95%, no complications requiring in-hospital treatment, full lung re-expansion after chest tube removal, and white blood cell count\<10×109/L.

Countries

China

Contacts

Primary ContactFei Cui, Ph.D, M.D.
cuidavil@hotmail.com08618902301212

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 24, 2026